The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiopoietin 2 Market Research Report 2025
Synopsis
The global Angiopoietin 2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiopoietin 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiopoietin 2.
Report Scope
The Angiopoietin 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiopoietin 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiopoietin 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Segment by Type
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiopoietin 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Angiopoietin 2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiopoietin 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiopoietin 2.
Report Scope
The Angiopoietin 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiopoietin 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiopoietin 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Segment by Type
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiopoietin 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Angiopoietin 2 Market Overview
1.1 Product Overview and Scope of Angiopoietin 2
1.2 Angiopoietin 2 Segment by Type
1.2.1 Global Angiopoietin 2 Market Value Comparison by Type (2024-2030)
1.2.2 Atu-111
1.2.3 BI-836880
1.2.4 LY-3127804
1.2.5 MEDI-3617
1.2.6 Others
1.3 Angiopoietin 2 Segment by Application
1.3.1 Global Angiopoietin 2 Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Angiopoietin 2 Market Size Estimates and Forecasts
1.4.1 Global Angiopoietin 2 Revenue 2019-2030
1.4.2 Global Angiopoietin 2 Sales 2019-2030
1.4.3 Global Angiopoietin 2 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Angiopoietin 2 Market Competition by Manufacturers
2.1 Global Angiopoietin 2 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Angiopoietin 2 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Angiopoietin 2 Average Price by Manufacturers (2019-2024)
2.4 Global Angiopoietin 2 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiopoietin 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiopoietin 2, Product Type & Application
2.7 Angiopoietin 2 Market Competitive Situation and Trends
2.7.1 Angiopoietin 2 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Angiopoietin 2 Players Market Share by Revenue
2.7.3 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiopoietin 2 Retrospective Market Scenario by Region
3.1 Global Angiopoietin 2 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Angiopoietin 2 Global Angiopoietin 2 Sales by Region: 2019-2030
3.2.1 Global Angiopoietin 2 Sales by Region: 2019-2024
3.2.2 Global Angiopoietin 2 Sales by Region: 2025-2030
3.3 Global Angiopoietin 2 Global Angiopoietin 2 Revenue by Region: 2019-2030
3.3.1 Global Angiopoietin 2 Revenue by Region: 2019-2024
3.3.2 Global Angiopoietin 2 Revenue by Region: 2025-2030
3.4 North America Angiopoietin 2 Market Facts & Figures by Country
3.4.1 North America Angiopoietin 2 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Angiopoietin 2 Sales by Country (2019-2030)
3.4.3 North America Angiopoietin 2 Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiopoietin 2 Market Facts & Figures by Country
3.5.1 Europe Angiopoietin 2 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Angiopoietin 2 Sales by Country (2019-2030)
3.5.3 Europe Angiopoietin 2 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiopoietin 2 Market Facts & Figures by Country
3.6.1 Asia Pacific Angiopoietin 2 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Angiopoietin 2 Sales by Country (2019-2030)
3.6.3 Asia Pacific Angiopoietin 2 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Angiopoietin 2 Market Facts & Figures by Country
3.7.1 Latin America Angiopoietin 2 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Angiopoietin 2 Sales by Country (2019-2030)
3.7.3 Latin America Angiopoietin 2 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiopoietin 2 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Angiopoietin 2 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Angiopoietin 2 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Angiopoietin 2 Sales by Type (2019-2030)
4.1.1 Global Angiopoietin 2 Sales by Type (2019-2024)
4.1.2 Global Angiopoietin 2 Sales by Type (2025-2030)
4.1.3 Global Angiopoietin 2 Sales Market Share by Type (2019-2030)
4.2 Global Angiopoietin 2 Revenue by Type (2019-2030)
4.2.1 Global Angiopoietin 2 Revenue by Type (2019-2024)
4.2.2 Global Angiopoietin 2 Revenue by Type (2025-2030)
4.2.3 Global Angiopoietin 2 Revenue Market Share by Type (2019-2030)
4.3 Global Angiopoietin 2 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Angiopoietin 2 Sales by Application (2019-2030)
5.1.1 Global Angiopoietin 2 Sales by Application (2019-2024)
5.1.2 Global Angiopoietin 2 Sales by Application (2025-2030)
5.1.3 Global Angiopoietin 2 Sales Market Share by Application (2019-2030)
5.2 Global Angiopoietin 2 Revenue by Application (2019-2030)
5.2.1 Global Angiopoietin 2 Revenue by Application (2019-2024)
5.2.2 Global Angiopoietin 2 Revenue by Application (2025-2030)
5.2.3 Global Angiopoietin 2 Revenue Market Share by Application (2019-2030)
5.3 Global Angiopoietin 2 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen Inc.
6.1.1 Amgen Inc. Corporation Information
6.1.2 Amgen Inc. Description and Business Overview
6.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Inc. Angiopoietin 2 Product Portfolio
6.1.5 Amgen Inc. Recent Developments/Updates
6.2 AnGes MG, Inc.
6.2.1 AnGes MG, Inc. Corporation Information
6.2.2 AnGes MG, Inc. Description and Business Overview
6.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AnGes MG, Inc. Angiopoietin 2 Product Portfolio
6.2.5 AnGes MG, Inc. Recent Developments/Updates
6.3 Boehringer Ingelheim GmbH
6.3.1 Boehringer Ingelheim GmbH Corporation Information
6.3.2 Boehringer Ingelheim GmbH Description and Business Overview
6.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio
6.3.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.4 Eli Lilly and Company
6.4.1 Eli Lilly and Company Corporation Information
6.4.2 Eli Lilly and Company Description and Business Overview
6.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly and Company Angiopoietin 2 Product Portfolio
6.4.5 Eli Lilly and Company Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 MedImmune, LLC
6.6.1 MedImmune, LLC Corporation Information
6.6.2 MedImmune, LLC Description and Business Overview
6.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MedImmune, LLC Angiopoietin 2 Product Portfolio
6.6.5 MedImmune, LLC Recent Developments/Updates
6.7 Regeneron Pharmaceuticals, Inc.
6.6.1 Regeneron Pharmaceuticals, Inc. Corporation Information
6.6.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio
6.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
6.8 RXi Pharmaceuticals Corporation
6.8.1 RXi Pharmaceuticals Corporation Corporation Information
6.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
6.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio
6.8.5 RXi Pharmaceuticals Corporation Recent Developments/Updates
6.9 Silence Therapeutics Plc
6.9.1 Silence Therapeutics Plc Corporation Information
6.9.2 Silence Therapeutics Plc Description and Business Overview
6.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Silence Therapeutics Plc Angiopoietin 2 Product Portfolio
6.9.5 Silence Therapeutics Plc Recent Developments/Updates
6.10 Synergys Biotherapeutics, Inc.
6.10.1 Synergys Biotherapeutics, Inc. Corporation Information
6.10.2 Synergys Biotherapeutics, Inc. Description and Business Overview
6.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio
6.10.5 Synergys Biotherapeutics, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiopoietin 2 Industry Chain Analysis
7.2 Angiopoietin 2 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiopoietin 2 Production Mode & Process
7.4 Angiopoietin 2 Sales and Marketing
7.4.1 Angiopoietin 2 Sales Channels
7.4.2 Angiopoietin 2 Distributors
7.5 Angiopoietin 2 Customers
8 Angiopoietin 2 Market Dynamics
8.1 Angiopoietin 2 Industry Trends
8.2 Angiopoietin 2 Market Drivers
8.3 Angiopoietin 2 Market Challenges
8.4 Angiopoietin 2 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
